Stocks in news: Stocks in news: Biocon, Nykaa, Britannia, Ta

Biocon has tentative approval from USFDA for Dasatinib Tablets, which are used to treat Philadelphia Chromosome Positive Chronic Myeloid Leukemia.

Related Keywords

India , Philadelphia , Pennsylvania , United States , , Axis Bank , Nestle , Britannia Ltd , Biocon , Max Financial , Dasatinib Tablets , Philadelphia Chromosome Positive Chronic Myeloid , Nestle India , Tata Consumer , Power Grid , Stocks In News , Nykaa , Britannia ,